LuisFPorrataMD
Hematology • Rochester, MNHematologic Oncology
Assistant Professor, Internal Medicine, Mayo Medical School
Dr. Porrata is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St SW
Rochester, MN 55905Phone+1 507-284-2511
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1996 - 2000- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1993 - 1996
SUNY Upstate Medical UniversityClass of 1993
Certifications & Licensure
MN State Medical License 1996 - 2025- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Agatolimod Sodium, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent or Refractory Non-Hodgkin Lymphoma Start of enrollment: 2004 Oct 01
- Two Different Methods of Collecting Stem Cells For an Autologous Stem Cell Transplant in Treating Patients With Diffuse Large Cell Lymphoma Start of enrollment: 2007 Dec 01
Publications & Presentations
PubMed
- 47 citationsInferior survival in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements is not associated with MYC/IG gene rearrangements.Ellen D. McPhail, Matthew J. Maurer, William R. Macon, Andrew L. Feldman, Paul J. Kurtin
Haematologica. 2018-11-01 - 256 citationsA phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma.T. E. Witzig, Craig B. Reeder, Betsy LaPlant, Mamta Gupta, Patrick B. Johnston
Leukemia. 2011-02-01 - 7 citationsThe International Prognostic Index predicts outcome after histological transformation of low-grade non-Hodgkin lymphomaIvana N. Micallef, Ellen D. Remstein, Stephen M. Ansell, Joseph P. Colgan, David J. Inwards
Leukemia & Lymphoma. 2006-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
